News

Lisbon’s Underdogs Gallery will soon launch the first solo exhibition of renowned contemporary artist, Paul Insect. Entitled ...
Elizabeth Allan, professor and head of the University of Maine's Hazing Prevention Research Lab, says the first step to ...
Bexicaserin is an investigational compound that is not approved for marketing by any regulatory authority worldwide. The ...
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that it will present data from its rare epilepsy pipeline at the 36th International Epilepsy Congress (IEC) being held August 30 – ...
Today marks 11 months since a federal judge signed off on the $600 million class action settlement between Norfolk Southern and residents who lived or worked within 20 miles of the 2023 East Palestine ...
Vormatrigine: Showcasing positive topline RADIANT results in FOS, updates from the first-in-human Phase 1 study, and further preclinical and clinical data supporting the accelerated advancement of the ...
Sunil Raj’s ‘Metancherry - a graphic animation’ is one among the huge package of animation films at the 17th IDSFFK ...
Learn about the Graham Foundation's 2025 awards for architecture, supporting exhibitions, publications, and public programs ...
Lundbeck A/S (Lundbeck) today announced that new data regarding bexicaserin, a novel treatment under investigation for seizures associated with Developmental and Epileptic Encephalopathies (DEEs), ...
Detailed price information for Stoke Therapeutics Inc (STOK-Q) from The Globe and Mail including charting and trades.
Official White House social media posts these days can more closely resemble troll-ish meme accounts than a sober ...